Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells. (Q42715412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

title

Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

main subject

multiple drug resistance

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Hua Naranmandura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

X Le

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Shi Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Yan Fang Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Micheal W Carew

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Wen Hui Hao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

9 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

published in

Archives of Toxicology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

1013-1023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23052202%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00204-012-0956-6

10 March 2020

exact match

0 references

cites work

Revisiting the differentiation paradigm in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenic toxicology: five questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Genetic toxicology of a paradoxical human carcinogen, arsenic: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Differential cytotoxic effects of arsenic compounds in human acute promyelocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

7. Organoarsenicals. Uptake, Metabolism, and Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Interaction of trivalent arsenicals with metallothionein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenic tolerance in Arabidopsis is mediated by two ABCC-type phytochelatin transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Study of interactions between arsenicals and thioredoxins (human and E. coli) using mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Analysis of arsenic metabolites in HepG2 and AS3MT-transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Identification of arsenic-binding proteins in human cells by affinity chromatography and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6

Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0956-6